What’s Happening in the RRP Community
What’s Happening in the RRP Community
Stay informed on the latest developments in RRP research, treatment advances, clinical trial opportunities, and advocacy efforts. This is your source for news that matters to patients, caregivers, and clinicians navigating the evolving landscape of recurrent respiratory papillomatosis care.
HPV-11 and Severe Pediatric Recurrent Respiratory Papillomatosis: Understanding the Link Between Viral Genotype and Disease Severity
A recently published study examined whether HPV genotype influences the severity of recurrent respiratory papillomatosis (RRP) in children. Researchers found that children with HPV-11 experienced significantly more aggressive disease, requiring more surgeries and demonstrating higher disease severity scores than those with HPV-6.
Gardasil as Adjunctive Therapy for Juvenile Recurrent Respiratory Papillomatosis: Evidence from South Africa
A groundbreaking study from South Africa explored the use of Gardasil® as an adjunctive therapy for juvenile-onset recurrent respiratory papillomatosis (JoRRP). Researchers observed substantial reductions in disease severity, longer intervals between surgeries, and lower tracheostomy rates, offering new evidence supporting the potential role of HPV vaccination in established RRP cases.
New Study Examines the Patient Perspective of Living with Recurrent Respiratory Papillomatosis
A newly published study in The Laryngoscope draws on data from the RRPF/CoRDS Patient Registry to quantify what our community has long known: RRP impacts far more than the airway. Here's what the research found.